These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 39223536)
21. Rectal versus vaginal progesterone administration for luteal phase support in the hormone replacement therapy frozen embryo transfer (HRT-FET) cycle: protocol for a non-inferiority randomised controlled trial. Alsbjerg B; Humaidan P BMJ Open; 2024 Jul; 14(7):e082879. PubMed ID: 38960462 [TBL] [Abstract][Full Text] [Related]
22. Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial. Tomic V; Tomic J; Klaic DZ; Kasum M; Kuna K Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():49-53. PubMed ID: 25622239 [TBL] [Abstract][Full Text] [Related]
23. A prospective randomized multicentre study comparing vaginal progesterone gel and vaginal micronized progesterone tablets for luteal support after in vitro fertilization/intracytoplasmic sperm injection. Bergh C; Lindenberg S; Hum Reprod; 2012 Dec; 27(12):3467-73. PubMed ID: 23019296 [TBL] [Abstract][Full Text] [Related]
24. Weekly intramuscular progesterone for luteal phase support in women receiving oocyte donation is associated with a decreased miscarriage rate. Delcour C; Robin G; Delesalle AS; Drumez E; Plouvier P; Dewailly D; Catteau-Jonard S Reprod Biomed Online; 2019 Sep; 39(3):446-451. PubMed ID: 31311693 [TBL] [Abstract][Full Text] [Related]
25. Subcutaneous versus vaginal progesterone for vitrified-warmed blastocyst transfer in artificial cycles. Turkgeldi E; Hanege BY; Yildiz S; Keles I; Ata B Reprod Biomed Online; 2020 Aug; 41(2):248-253. PubMed ID: 32532668 [TBL] [Abstract][Full Text] [Related]
27. Prospective, randomized study to evaluate the success rates using hCG, vaginal progesterone or a combination of both for luteal phase support. Ludwig M; Finas A; Katalinic A; Strik D; Kowalcek I; Schwartz P; Felberbaum R; Küpker W; Schöpper B; Al-Hasani S; Diedrich K Acta Obstet Gynecol Scand; 2001 Jun; 80(6):574-82. PubMed ID: 11380297 [TBL] [Abstract][Full Text] [Related]
28. Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials. Doblinger J; Cometti B; Trevisan S; Griesinger G PLoS One; 2016; 11(3):e0151388. PubMed ID: 26991890 [TBL] [Abstract][Full Text] [Related]
29. Vaginal gel versus intramuscular progesterone for luteal phase supplementation: a prospective randomized trial. Dal Prato L; Bianchi L; Cattoli M; Tarozzi N; Flamigni C; Borini A Reprod Biomed Online; 2008 Mar; 16(3):361-7. PubMed ID: 18339258 [TBL] [Abstract][Full Text] [Related]
30. Micronized progesterone plus dydrogesterone versus micronized progesterone alone for luteal phase support in frozen-thawed cycles (MIDRONE): a prospective cohort study. Vuong LN; Pham TD; Le KTQ; Ly TT; Le HL; Nguyen DTN; Ho VNA; Dang VQ; Phung TH; Norman RJ; Mol BW; Ho TM Hum Reprod; 2021 Jun; 36(7):1821-1831. PubMed ID: 33930124 [TBL] [Abstract][Full Text] [Related]
31. Efficacy, safety and tolerability of progesterone vaginal pessaries versus progesterone vaginal gel for luteal phase support after in vitro fertilisation: a randomised controlled trial. Saunders H; Khan C; D'Hooghe T; Magnúsdóttir TB; Klingmann I; Hrafnsdóttir S; Hum Reprod; 2020 Feb; 35(2):355-363. PubMed ID: 32074281 [TBL] [Abstract][Full Text] [Related]
32. Duration of luteal support (DOLS) with progesterone pessaries to improve the success rates in assisted conception: study protocol for a randomized controlled trial. Gazvani R; Russell R; Sajjad Y; Alfirevic Z Trials; 2012 Jul; 13():118. PubMed ID: 22834768 [TBL] [Abstract][Full Text] [Related]
33. Effect of different luteal support schemes on clinical outcome in frozen-thawed embryos transfer cycles. Zhang Z; Su D; Zhu P; Bi X; Qi G; Wu X Clin Exp Obstet Gynecol; 2016; 43(4):486-489. PubMed ID: 29734532 [TBL] [Abstract][Full Text] [Related]
34. Luteal support for IVF/ICSI cycles with Crinone 8% (90 mg) twice daily results in higher pregnancy rates than with intramuscular progesterone. Ho CH; Chen SU; Peng FS; Chang CY; Yang YS J Chin Med Assoc; 2008 Aug; 71(8):386-91. PubMed ID: 18772117 [TBL] [Abstract][Full Text] [Related]
35. Vaginal versus intramuscular progesterone for luteal phase support in assisted reproductive techniques: a systematic review and meta-analysis of randomized controlled trials. Abdelhakim AM; Abd-ElGawad M; Hussein RS; Abbas AM Gynecol Endocrinol; 2020 May; 36(5):389-397. PubMed ID: 32054365 [TBL] [Abstract][Full Text] [Related]
36. Comparison of four protocols for luteal phase support in frozen-thawed Embryo transfer cycles: a randomized clinical trial. Zarei A; Sohail P; Parsanezhad ME; Alborzi S; Samsami A; Azizi M Arch Gynecol Obstet; 2017 Jan; 295(1):239-246. PubMed ID: 27761732 [TBL] [Abstract][Full Text] [Related]
37. Comparable Outcomes Using Oral Dydrogesterone Vs. Micronized Vaginal Progesterone in Frozen Embryo Transfer: a Retrospective Cohort Study. Atzmon Y; Aslih N; Estrada D; Bilgory A; Ellenbogen A; Shalom-Paz E Reprod Sci; 2021 Jul; 28(7):1874-1881. PubMed ID: 33140324 [TBL] [Abstract][Full Text] [Related]
38. Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer. Mui Lam P; Chun Cheung M; Ping Cheung L; Ingrid Lok H; John Haines C Gynecol Endocrinol; 2008 Dec; 24(12):674-80. PubMed ID: 19172535 [TBL] [Abstract][Full Text] [Related]
39. The impact of luteal serum progesterone levels on live birth rates-a prospective study of 602 IVF/ICSI cycles. Thomsen LH; Kesmodel US; Erb K; Bungum L; Pedersen D; Hauge B; Elbæk HO; Povlsen BB; Andersen CY; Humaidan P Hum Reprod; 2018 Aug; 33(8):1506-1516. PubMed ID: 29955789 [TBL] [Abstract][Full Text] [Related]
40. [Intramuscular vs vaginal progesterone for luteal support in cycles of in vitro fertilization]. Marianowski P; Radwańska E Ginekol Pol; 2000 Sep; 71(9):1064-70. PubMed ID: 11082976 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]